Biblio
Circulating Tumor DNA in Lymphoma: Principles and Future Directions. Blood Cancer Discov. 2022;3(1):5-15.
. Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models. Blood Adv. 2020;4(18):4451-4462.
High-throughput genomic profiling of tumor-infiltrating leukocytes. Curr Opin Immunol. 2016;41:77-84.
. Hit-and-run lymphomagenesis by the Bcl6 oncogene. Cell Cycle. 2014;13(12).
. A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment. Cell Stem Cell. 2024.
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell. 2021.
Molecular Monitoring of Lymphomas. Annu Rev Pathol. 2022.
. Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition. Cell. 2020.
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma. Ann Hematol. 2023.
Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA. Semin Radiat Oncol. 2015;25(4):305-312.
. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015.
Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015.
.